Ultrastructural Documentation of HLA-DR Antigen Reactivity in Normal Human Acrosyringial Epithelium  by Murphy, George F. et al.
0022-202X/83/8102-0181$02.00/ 0 
THE JOURNAL OF I NVESTIGATIVE DERMATOLOGY, 81:181- 183, 1983 
Copyright © 1983 by The Williams & Wilkins Co. 
Vol. 81, No.2 
Printed in U.S.A. 
Ultrastructural Documentation ofHLA-DR Antigen Reactivity in Normal 
Human Acrosyringial Epithelium 
GEORGE F. MURPHY, M.D., RICHARD S . SHEPARD, M.A., TERENCE J. HARRIST, M.D., 
BEN R. BRONSTEIN, M.D., AND ATUL K . BHAN, M.D. 
Department of Pathology, Dermatopathology Laboratory, The Brigham and Women's Hospital; the Dermatopathology and 
Immunopathology Divisions, Massachusetts General Hospital; and the Department of Pathology, Harvard Medical School, 
Boston, Massachusetts, U.S.A . 
We have observed that monoclonal antibodies directed 
against human la-like antigens react with a subset of 
e pidermal keratinocytes as well as Langerhans cells in 
normal human skin. Membrane reactivity for HLA-DR 
antigen in flattened ductal keratinocytes and in adjacent 
cuticular cells forming the acrosyringial lumen was ob-
served using immunoelectron microscopy. It should be 
recognized that !a-positive acrosyringial keratinocytes 
represent a potential source of contamination in 
methods designed to study and isolate Langerhans cells 
using antibodies directed against HLA-DR antigens. Te-
leologic considerations of HLA-DR antigen expression 
in the acrosyringium are discussed. 
It is generally believed that Langerhans cells (LC) are the 
only constituents of normal human epidermis that express 
HLA-DR antigen, an analogue of the mmine immune response-
associated (la) antigens [1,2]. Methods for the detection [3] and 
isolation [ 4] of LC have therefore re lied on immunologic strat-
egies using anti-HLA-DR antibodies. Although LC, which com-
pose 2-5% of the epidermal cell population, may be consistently 
identified with monoclonal anti-T6 antibody in normal skin, 
only a subset of these are identified by anti-HLA-DR antibody 
[5-7]. Surprisingly, m e thods using a nti-HLA-DR antibodies to 
identify LC in normal epidermal cell suspensions have yielded 
numbers approximately equal to the expected number of T6-
positive LC [ 4]. One possible explanation for this apparent 
discrepancy is that some keratinocytes also express HLA-DR 
antigens in normal skin. 
In the course of identifying a variety of skin antigens with 
monoclonal antibodies [8- 14], we observed that the epithelium 
lining the acrosyringium and distal portion of the dermal eccrine 
duct had reactivity with anti-HLA-DR antibody by light mi-
croscopy [5,6]. This was also observed in isolated eccrine duct 
segments obtained by trypsinization. Application of immuno-
electron microscopy confirmed this finding and further char-
acterized this reactivity. These observations provide evidence 
t hat specialized keratinocytes, as well as LC, are capable of 
showing reactivity with a ntibodies directed against !a-like an-
tigens. 
MATERIALS AND METHODS 
Patients 
Punch biopsies (4 mm) were obtained from the upper arms of 3 
healthy male volunteers and a fow-th specimen of normal skin was 
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DAB: 3',3' -diaminobenzidine 
FCS: fetal calf serum 
LC: Langerhans cell(s) 
PBS: phosphate-buffered saline 
obtained from the upper arm after sw-gical amputation for a nonder-
matologic neoplasm. Punch biopsies were obtained using a Keyes punch 
instrument with 1% Xylocaine anesthesia without epineplu:ine. Biopsy 
specimens were subdivided into 1 rum-thick slabs and initially fixed 
with 4% paraformaldehyde in 0.1 M phosphate-buffered saline (PBS, 
pH 7.4) containing 8% sucrose for 3 h at 4°C [15]. After subsequent 
washing in PBS containing 8% sucrose, specimens were rapidly frozen 
in Optimum Cutting Temperature (OCT) compound (Ames Co., Divi-
sion of Miles Laboratories, Elkhart, Indiana) by suspension in liquid 
nitrogen, cryostat sectioned at 15 p.rn, and mounted on gelatin-coated 
slides. 
Epidermal Cell Suspensions 
Suspensions of epidermal cells were prepared from normal skin 
obtained during plastic sw-gical procedw-es (reduction mammoplasty) 
ut ilizing a modification of the technique of E isinger et al [16]. Using 
sharp dissection, all subcutaneous tissue and as much dermis as possible 
were removed from the specimen, which was then cut into strips 5 mm 
long x 2 mm wide. The strips were incubated in 20 mM EDTA solu tion 
[17] for 1 h at 37°C and then in 0.25% trypsin (1:250, Grand Island 
Biological Co. (Gibco), Grand Island, New York) at 4°C for 16 h. The 
epidermis was easily separated from the dermis and the epidermal 
strips were gently teased apart in a trypsin/ EDTA solution (1:250 
trypsin in Hanks' balanced salt solu tion without calcium or magnesium, 
Gibco). A suspension was prepared by repeatedly pipetting the fine 
strips with a 10-cc pipette. Trypsinization was terminated by adding 
10% fetal calf serum (FCS) and the suspension was filtered through a 
wire mesh to remove cell clumps. Cells were concentrated by centrifu-
gation and resuspension was performed a second time. Total cell counts 
were made by hemocytometer and viability assessed by trypan blue 
exclusion. Immunostaining was performed on cytosmears. 
Antibodies 
The monoclonal antibodies, anti-I (OKil) , anti-T6 (0KT6) and anti-
T 3 (OKT3), were used (Ortho Pharmaceuticals, Raritan, New Jersey). 
Control ascitic fluid was obtained from animals injected with nonse-
creting hybridoma cells. Anti-ll ant ibody [18] reacts with the nonpo-
lymorphic region of human !a-like ant igens. Ant i-T6 ant ibody reacts 
with 70% of thymocytes but not with peripheral T cells. Anti-T6 
antibody also reacts with intraepidermal LC and indeterminate cells in 
the dermis [9,14]. Anti-T3 an tibody reacts with 100% of peripheral E-
rosette-positive cells and approximately 10% of thymocytes [19,20]. 
Immunop eroxidase Procedures 
Two methods of immunoperoxidase staining were used. The first 
was a highly sensit ive 4-step immunoperoxidase technique using per-
oxidase-antiperoxidase complex. Frozen t issue sections were overlaid 
with 25 ,.U of a 1:500 dilution of ant ibody and buffet· containing either 
anti-Il, anti-T6, or anti-T3 antibodies and incubated for 60 min in a 
moist chamber at room temperature. Then, sections were incubated 
sequentially with a 1:40 dilution of rabbit and antimouse Ig serum 
(Dako Immunoglobulins, Copenhagen, Denmark) , a 1:40 dilution of 
swine ant irabbit lg antiserum (Dako) , and a 1:50 dilution of peroxidase 
rabbit antiperoxidase reagent (PAP) (Dako) for 20- 30 min. Sections 
were rinsed in PBS between incubations. Further details of this pro-
cedw-e are reported elsewhere [21,22]. 
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The second technique employed primary monoclonal antibodies, a 
biotinylated secondary an tibody, and an avidin-bio tin-horseradish per-
oxidase complex (Vector Laboratories, Inc., Burlingame, California). 
This technique has been described in detail [23]. All sections were 
stained with 3',3'-diaminobenzidine (DAB) (Sigma, St. Louis, Missouri) 
for 30-, 60-, 90-, and 120-s intervals, rinsed in PBS to terminate the 
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staining reaction, and examined by light microscopy prior to further 
processing for electron microscopy. All cytosmears of epidermal cell 
suspensions were processed using this method. 
Electron Microscopy 
Immunoperoxidase-stained sections were fixed with 2% glutaralde-
hyde in PBS for 20 min at room temperature and stored in Karnovsky's 
solution overnight at 4°C. Sections were postfixed with 2% osmium 
tetroxide, dehydrated in graded ethanol solutions, and embedded in an 
Epon-araldite mixture in inverted gelatin capsules. Ultrathin sections 
were cut with a Porter Blum MT-2 ultramicrotome and both unstained 
sections and sections stained with uranyl acetate and lead citrate were 
examined with a Joel JSM-100 electron microscope. 
RESULTS 
Examination using light microscopy revealed that the inner 
cell layers of the acrosyringium and superficial portion of the 
dermal eccrine duct had apparent peripheral staining for HLA-
DR antigen, whereas the deep portion of the duct and secretory 
coil were negative (Fig 1) . Similar reactivity was observed in 
isolated intact eccrine duct segments in epidermal cell suspen-
sions (Fig 2). Other cells with anti-Il antibody reactivity in-
cluded dendritic cells of the midepidermis, vascular endothe-
lium, and rare dermal mononuclear cells. Anti-T6 antibody 
reacted only with intraepidermal dendritic cells, and anti-T3 
antibody reacted only with rare dermal mononuclear cells ad-
jacent to superficial venules. 
Electron microscopic examination revealed anti-Il antibody 
reactivity to be localized to the cell membranes of keratinocytes 
adjacent to the cuticular cells forming acrosyringial lumina 
(Figs 3, 4) . The DAB reaction product, indicating sites of 
membrane reactivity, was uniformly distributed along the mem-
branes of these cells (Fig 5). Occasional small foci of similar 
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staining were observed on the more compressed cuticular cells. 
Anti-ll antibody reactivity was focally noted in the amorphous 
intraluminal secretions. Nearby LC showed variable staining 
with anti-Il antibody and uniform reactivity with anti-T6 an-
tibody. Anti-T6 and anti-T3 antibodies showed no reactivity 
with acrosyringial epithelium. 
DISCUSSION 
It has been widely held that normal human keratinocytes do 
not express HLA-DR antigens [1,24], although animal studies 
have produced conflicting results [25- 28]. Our findings indicate 
that keratinocytes of the acrosyringium are reactive with anti-
HLA-DR antibodies. Because the density of eccrine glands 
varies significantly in different anatomic sites, tissue sampling 
may in part be responsible for the previously reported apparent 
absence of keratinocyte reactivity. 
The recognition of HLA-DR antigen reactivity by acrosyrin-
gial keratinocytes is fundamental to immunologic strategies for 
LC purification. HLA-DR-positive epidermal cells from the 
acrosyringium may contaminate LC-enriched suspensions ob-
tained using anti-HLA-DR antibodies alone. 
The precise nature of HLA-DR antigen presence on acrosy-
ringial keratinocytes is uncertain. Possible explanations include 
(1) shedding of antigen from nearby LC, (2) passive deposition 
of antigen from eccrine secretions, and (3) active expression and 
possible secretion of antigen by the acrosyringial lining 
cells. Although HLA-DR antigen shedding is a proposed 
mechanism whereby cells may acquire HLA-DR positivity [29, 
30], LC were infrequently encountered in the acrosyringium in 
areas where the epithelium was positively stained. It is equally 
unlikely that HLA-DR antigen is passively deposited from 
eccrine secretions, since the proximal eccrine ducts, the secre-
FIG 1. Normal human skin incubated 
with monoclonal anti-HLA-DR anti-
body. Note staining of the lining cells of 
the acrosyringial lumen (arrows) within 
the epidermis (EP/) (avidin-biotin-
horseradish peroxidase complex proce-
dure, X 250). 
FIG 2. Normal human epidermal cell 
suspension obtained by trypsinization. 
Intact cell aggregates with central lu-
mina, consistent with eccrine duct (ED) 
segments, as well as isolated cells, pre-
sumably Langerhans cells (LC) , stained 
with anti-HLA-DR antibody (avidin-
biotin-horseradish peroxidase complex 
procedure, X 250) . 
FIG 3. Transmission electron micro-
graph of a normal human acrosyringium. 
The lumen (L) is lined by flattened cu-
ticular cells and acrosyringial epithelium 
(A). 
FIG 4. Immunoelectron micrograph of 
a normal human acrosyringium. E lec-
tron-dense reaction product of DAB, in-
dicating sites of anti-HLA-DR antibody 
reactivity, are present focally along the 
cell membranes of acrosyringial epithe-
lium (A) forming the duct lumen (L). 
FIG 5. Immunoelectron micrograph 
showing discrete localization of DAB re-
action product along the cell membranes 
of acrosyringial epithelium. Anti-HLA-
DR reactivity was not detected in cyto-
plasmic organelles. 
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tory coils, and their contents uniformly showed no HLA-DR 
staining by immunoelectron microscopy. The expression of 
HLA-DR antigen by epidermal keratinocytes has been sug-
gested in psoriasis [20] and has been observed in other disorders 
in the skin [31] (Bhan and Hanist, unpublished observations). 
In normal ductular epithelium, HLA-DR antigens have been 
detected in the lactiferous ducts of the breast [32], a structure 
analogous to an apocrine gland. 
The acrosyringium serves as a terminal conduit for the pas-
s~ge of eccrine secretions. However, its structure is complex, 
w1th an elaborate corkscrew pattern. It is intriguing to speculate 
a purpose for this configuration, such as a m eans of increasing 
absorptive, or possibly secretory, surface area. Glycoproteins 
have been documented in human eccrine sweat [33], although 
t hey are incompletely characterized [34]. In lower animals, 
secreted proteins may trigger responses promoting genetically 
desirable mating patterns (35]. Whether shedding of histocom-
patibility antigens in eccrine secretions represents a remnant in 
humans of such a mechanism remains to be determined. 
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